Status:

COMPLETED

Remote Bimanual Virtual Rehabilitation Post CVD

Lead Sponsor:

Grigore Burdea

Collaborating Sponsors:

Kessler Foundation

Conditions:

Stroke Sequelae

Cognitive Impairment

Eligibility:

All Genders

48-80 years

Phase:

NA

Brief Summary

The aim of the study is to develop the BrightBrainer G (grasp), a game-based upper-extremity motor and cognitive rehabilitation system using custom virtual reality simulations. The G model is a versio...

Detailed Description

8 elderly subjects (50 to 80 years old) who live at home and had a stroke more than 9 months prior to participation, who may also suffer from mild cognitive impairments and may be depressed, will be r...

Eligibility Criteria

Inclusion

  • Age 48 to 80;
  • Diagnosis of stroke which occurred more than 9 months prior (i.e. in the chronic phase);
  • English speakers;
  • UE unilateral motor involvement (FMA score 10 to 45);
  • Be able to actively move UE more than 15 degrees for shoulder and for elbow flexion/extension;
  • Be more than 4 months post casting procedures or Botulinum toxin injections;
  • Have cognitive skills to participate (Montreal Cognitive Assessment score 18-30).
  • Potential participants will not be excluded due to co-morbidities such as Parkinson, frozen shoulder, or arthritis;
  • Have normal cognition or MCI.

Exclusion

  • Be younger than 48 or older than 80;
  • Present with severe visual neglect or legally blind;
  • Have severe hearing loss or deafness;
  • Present with receptive aphasia or severe expressive aphasia;
  • Have uncontrolled hypertension (\>190/100 mmHg);
  • Have severe cognitive delay;
  • Cannot speak English;
  • Have history of violence or drug abuse;
  • Participants who cannot produce reliable scores on the neuropsychological pre-study assessment because they do not comprehend the test, or have severe speech impairment will be excluded;
  • Have severe hand spasticity and/or complete lack of arm movement;
  • MoCA scores of 17 and below.

Key Trial Info

Start Date :

September 30 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 13 2018

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04713384

Start Date

September 30 2015

End Date

September 13 2018

Last Update

July 21 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kessler Foundation

West Orange, New Jersey, United States, 07052